Boscalid
- Generic Name
- Boscalid
- Drug Type
- Small Molecule
- Chemical Formula
- C18H12Cl2N2O
- CAS Number
- 188425-85-6
- Unique Ingredient Identifier
- 32MS8ZRD1V
- Background
Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others.
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
Phase 4
Completed
- Conditions
- Primary Sjogren SyndromeSecondary Sjogren SyndromeAqueous Deficient Dry Eye DiseaseEvaporative Dry Eye Disease
- Interventions
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Federal University of São Paulo
- Target Recruit Count
- 100
- Registration Number
- NCT02004067
- Locations
- 🇧🇷
Departamento de Oftalmologia da Escola Paulista de Medicina - UNIFESP, Sao Paulo, SP, Brazil
Topical Cyclosporine and Disease Progression
Phase 4
Completed
- Conditions
- Disease ProgressionDisease SeverityStainingSchirmersOSDI
- Interventions
- First Posted Date
- 2007-12-05
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Innovative Medical
- Target Recruit Count
- 80
- Registration Number
- NCT00567983
- Locations
- 🇺🇸
Lakeside Eye Clinic, Chicago, Illinois, United States
Oasys vs. Extreme H20 Xtra 59
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2008-02-18
- Lead Sponsor
- Innovative Medical
- Target Recruit Count
- 52
- Registration Number
- NCT00477763
- Locations
- 🇺🇸
Hazleton Eye Specialists, Hazleton, Pennsylvania, United States
Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Wills Eye
- Target Recruit Count
- 43
- Registration Number
- NCT00405431
- Locations
- 🇺🇸
Wills Eye Glaucoma Service, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath